Pfizer Inc. and Bayer said on March 14 they would maintain humanitarian supply of medicines to Russia, but would pull back from other non-essential spending in the country.

The Centers for Disease Control and Prevention (CDC) awarded Palantir Technologies Inc. a $5.3 million contract to manage distribution of COVID-19 drugs in the United States, the software maker said on February 22.

Gilead Sciences issued a statement describing the company’s efforts of scaling up manufacturing and distribution of the antiviral drug remdesivir as a treatment for COVID-19.

CVS Health Corp.’s pharmacy benefit management (PBM) unit is launching a new program under which employers and insurers will be able to offer diabetes drugs, including insulin, at no out-of-pocket costs to their members.